Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of a Four-level Chinese Emergency Triage Scale in Mainland China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03926234
Recruitment Status : Active, not recruiting
First Posted : April 24, 2019
Last Update Posted : February 12, 2020
Sponsor:
Information provided by (Responsible Party):
Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary:
Inter-rater reliability between experts and triage nurses was assessed in 484 emergency patients. The criterion-related validity was evaluated in other 30687 emergency patients, based on emergency department (ED) mortality, the length of stay in ED, the number of discharge, and hospitalization (intensive care/general ward).

Condition or disease Intervention/treatment
Emergencies Triage Other: Four-level Chinese Emergency triage scale

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30687 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Reliability and Validity of a Four-level Chinese Emergency Triage Scale in Mainland China
Actual Study Start Date : January 1, 2018
Actual Primary Completion Date : December 31, 2019
Estimated Study Completion Date : June 30, 2020

Group/Cohort Intervention/treatment
emergency triage patients
triage Level I triage Level II triage Level III triage Level IV
Other: Four-level Chinese Emergency triage scale
a four-level category system, i.e. life-threatening (Level I), emergent (Level II), urgent (Level III) and semi-urgent (Level IV) . This system contains critical indicators (cardiac arrest, shock, and apnea), high risk indicators (ACS and DKA), single objective indicators (SBP, RR, HR, and SpO2) and MEWS (synthesis indicator). According to patients' health care problems, patients are rated by nurses into one of the four mentioned levels.




Primary Outcome Measures :
  1. Inter-rater reliability [ Time Frame: 2019-10-1 ]
    inter-rater reliability as the agreement between triage nurses and experts

  2. emergency department (ED) mortality [ Time Frame: 2019-12-31 ]
  3. the number of discharge [ Time Frame: 2019-12-31 ]

Secondary Outcome Measures :
  1. the number of hospitalization [ Time Frame: 2019-12-31 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All eligibility emergency patients
Criteria

Inclusion Criteria:

  • Patients, older than 14 years and admitted to the ED, were eligible for this study.

Exclusion Criteria:

  • Gynecologic and obstetric emergencies
  • Patients, who left against medical advice or hadn't been aided by a doctor

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03926234


Locations
Layout table for location information
China
SAHZhejiangU
Hangzhou, China, 310009
Sponsors and Collaborators
Second Affiliated Hospital, School of Medicine, Zhejiang University
Layout table for additonal information
Responsible Party: Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier: NCT03926234    
Other Study ID Numbers: 2018ZH012
First Posted: April 24, 2019    Key Record Dates
Last Update Posted: February 12, 2020
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes